Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice

[1]  L. Nagy,et al.  PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors , 2014, Cardiovascular Diabetology.

[2]  O. Volger,et al.  Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization. , 2014, Antioxidants & redox signaling.

[3]  M. Young,et al.  Biglycan modulates angiogenesis and bone formation during fracture healing. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[4]  T. Koh,et al.  Low-Intensity Vibration Improves Angiogenesis and Wound Healing in Diabetic Mice , 2014, PloS one.

[5]  C. Decaestecker,et al.  VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis , 2013, PloS one.

[6]  N. Zanou,et al.  Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways , 2013, Cellular and Molecular Life Sciences.

[7]  V. Notario,et al.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential , 2013, Nature Reviews Cancer.

[8]  L. Messina,et al.  Type 2 Diabetes Restricts Multipotency of Mesenchymal Stem Cells and Impairs Their Capacity to Augment Postischemic Neovascularization in db/db Mice , 2012, Journal of the American Heart Association.

[9]  A. Józkowicz,et al.  Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice , 2012, Cardiovascular research.

[10]  J. Engele,et al.  Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration. , 2012, Experimental cell research.

[11]  H. Tse,et al.  Endothelium-Selective Activation of AMP-Activated Protein Kinase Prevents Diabetes Mellitus–Induced Impairment in Vascular Function and Reendothelialization via Induction of Heme Oxygenase-1 in Mice , 2012, Circulation.

[12]  Shi-Yong Neo,et al.  Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment , 2012, Cancer and Metastasis Reviews.

[13]  S. Thorsteinsdóttir,et al.  Fibronectin promotes migration, alignment and fusion in an in vitro myoblast cell model , 2012, Cell and Tissue Research.

[14]  M. Cieśla,et al.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. , 2012, Antioxidants & redox signaling.

[15]  L. Gurke,et al.  FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia , 2011, Journal of cellular and molecular medicine.

[16]  T. Koh,et al.  Impaired Muscle Regeneration in Ob/ob and Db/db Mice , 2011, TheScientificWorldJournal.

[17]  E. Van Obberghen-Schilling,et al.  Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. , 2011, The International journal of developmental biology.

[18]  T. Hawke,et al.  Inhibition of Plasminogen Activator Inhibitor-1 Restores Skeletal Muscle Regeneration in Untreated Type 1 Diabetic Mice , 2011, Diabetes.

[19]  T. Hawke,et al.  Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms , 2011, Pediatric diabetes.

[20]  D. Stewart,et al.  Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  P. Choong,et al.  Pigment epithelium‐derived factor as an impending therapeutic agent against vascular epithelial growth factor‐driven tumor‐angiogenesis , 2011, Molecular carcinogenesis.

[22]  M. Patti,et al.  Early life nutrition modulates muscle stem cell number: implications for muscle mass and repair. , 2011, Stem cells and development.

[23]  Zhao-Jun Liu,et al.  Identification of E-selectin as a Novel Target for the Regulation of Postnatal Neovascularization: Implications for Diabetic Wound Healing , 2010, Annals of surgery.

[24]  S. Ferrari,et al.  Proline Isomerase Pin1 Represses Terminal Differentiation and Myocyte Enhancer Factor 2C Function in Skeletal Muscle Cells* , 2010, The Journal of Biological Chemistry.

[25]  K. Matrougui,et al.  Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice , 2010, Laboratory Investigation.

[26]  Jinhwa Lee.  Role of cyclophilin a during oncogenesis , 2010, Archives of pharmacal research.

[27]  Defa Li,et al.  High glucose induces differentiation and adipogenesis in porcine muscle satellite cells via mTOR. , 2010, BMB reports.

[28]  L. Messina,et al.  Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. , 2009, Journal of vascular surgery.

[29]  A. Ferro,et al.  Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes , 2009, Clinical and experimental pharmacology & physiology.

[30]  J. Borén,et al.  Protein disulfide isomerase increases in myocardial endothelial cells in mice exposed to chronic hypoxia: a stimulatory role in angiogenesis. , 2009, American journal of physiology. Heart and circulatory physiology.

[31]  R. Rizzi,et al.  Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus , 2009, Journal of cellular and molecular medicine.

[32]  R. McPherson,et al.  Increased susceptibility to oxidative damage in post-diabetic human myotubes , 2009, Diabetologia.

[33]  Y. Hérault,et al.  Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice , 2009, PloS one.

[34]  C. Rathbone,et al.  Satellite cell-mediated angiogenesis in vitro coincides with a functional hypoxia-inducible factor pathway. , 2009, American journal of physiology. Cell physiology.

[35]  G. Invernici,et al.  Human CD133+ Progenitor Cells Promote the Healing of Diabetic Ischemic Ulcers by Paracrine Stimulation of Angiogenesis and Activation of Wnt Signaling , 2009, Circulation research.

[36]  R. A. Howlett,et al.  Muscle‐specific VEGF deficiency greatly reduces exercise endurance in mice , 2009, The Journal of physiology.

[37]  A. L'Abbate,et al.  Diabetes Impairs the Vascular Recruitment of Normal Stem Cells by Oxidant Damage, Reversed by Increases in pAMPK, Heme Oxygenase-1, and Adiponectin , 2009, Stem cells.

[38]  L. Leng,et al.  Tumor growth-promoting properties of macrophage migration inhibitory factor. , 2008, Current pharmaceutical design.

[39]  K. Walsh,et al.  Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism* , 2008, Journal of Biological Chemistry.

[40]  Zhao-Jun Liu,et al.  Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. , 2008, Antioxidants & redox signaling.

[41]  X. Ren,et al.  Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  X. Ren,et al.  Paracrine action of HO‐1‐modified mesenchymal stem cells mediates cardiac protection and functional improvement , 2008, Cell biology international.

[43]  J. Cisowski,et al.  Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. , 2008, Antioxidants & redox signaling.

[44]  S. yet,et al.  Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. , 2008, Journal of molecular and cellular cardiology.

[45]  J. Bernhagen,et al.  Macrophage Migration Inhibitory Factor in Cardiovascular Disease , 2008, Circulation.

[46]  M. Rudnicki,et al.  The emerging biology of satellite cells and their therapeutic potential. , 2008, Trends in molecular medicine.

[47]  M. Dieterlen,et al.  The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCζ , 2007, Journal of Cell Science.

[48]  F. Bach,et al.  Therapeutic applications of bilirubin and biliverdin in transplantation. , 2007, Antioxidants & redox signaling.

[49]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[50]  G. Bassez,et al.  Muscle satellite cells and endothelial cells: close neighbors and privileged partners. , 2007, Molecular biology of the cell.

[51]  H. Haider,et al.  Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. , 2007, Journal of molecular and cellular cardiology.

[52]  G. Siegal,et al.  Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism , 2007, The Journal of experimental medicine.

[53]  A. Avogaro,et al.  Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats , 2006, Diabetologia.

[54]  S. Tapscott,et al.  MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206 , 2006, The Journal of cell biology.

[55]  E. Brandan,et al.  Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[56]  J. Drukała,et al.  Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. , 2006, Free radical biology & medicine.

[57]  Benjamin J. Kraus,et al.  Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[58]  M. Layne,et al.  Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. , 2005, Diabetes.

[59]  Y. Lim,et al.  Human VEGF165-myoblasts produce concomitant angiogenesis/myogenesis in the regenerative heart. , 2004, Molecular and cellular biochemistry.

[60]  A. Takeshita,et al.  Gene Transfer of Stromal Cell–Derived Factor-1&agr; Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase–Related Pathway: Next-Generation Chemokine Therapy for Therapeutic Neovascularization , 2004, Circulation.

[61]  M. Young,et al.  Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. , 2004, Developmental biology.

[62]  L. DiPietro,et al.  Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.

[63]  J. Isner,et al.  Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.

[64]  D. Scholz,et al.  Angiogenesis and myogenesis as two facets of inflammatory post-ischemic tissue regeneration , 2002, Molecular and Cellular Biochemistry.

[65]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[66]  J. Peña,et al.  Capillary Supply During Development of Individual Regenerating Muscle Fibers , 1995, Anatomia, histologia, embryologia.

[67]  Guy Hoffman,et al.  Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. , 1993, The Journal of clinical investigation.

[68]  M. Dodson,et al.  Satellite cells derived from streptozotocin-diabetic rats display altered fusion parameters in vitro. , 1989, Metabolism: clinical and experimental.

[69]  Feodor Price,et al.  Satellite cells and the muscle stem cell niche. , 2013, Physiological reviews.

[70]  M. Trebak,et al.  Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice. , 2012, The American journal of pathology.

[71]  A. Agarwal,et al.  Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. , 2011, American journal of physiology. Renal physiology.

[72]  C. Emanueli,et al.  Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia. , 2007, Frontiers in bioscience : a journal and virtual library.

[73]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[74]  D. Watt,et al.  The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration , 2004, Glycoconjugate Journal.